Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Gritstone bio, Inc. | PRESIDENT AND CEO, Director | Common Stock | 1.12M | $841K | $0.75 | Jun 24, 2024 | Indirect |
Gritstone bio, Inc. | PRESIDENT AND CEO, Director | Common Stock | 985K | $737K | $0.75 | Jun 24, 2024 | Direct |
Gritstone bio, Inc. | PRESIDENT AND CEO, Director | Common Stock | 325K | $243K | $0.75 | Jun 24, 2024 | Allen 2024 Gift Trust |
Epizyme, Inc. | Director | Common Stock, par value $0.0001 | 20.6K | $29K | $1.41 | Jun 11, 2021 | Direct |
Adaptimmune Therapeutics PLC | Director | Option to purchase Ordinary Shares | 660K | Jul 1, 2024 | Direct | ||
Gritstone bio, Inc. | PRESIDENT AND CEO, Director | Stock Option (Right to Buy) | 615K | May 15, 2024 | Direct | ||
Epizyme, Inc. | Director | Stock Option (Right to Buy) | 40.6K | Jun 11, 2021 | Direct | ||
Sierra Oncology, Inc. | Director, 10%+ Owner | Common Stock | 0 | $55.00 | Jul 1, 2022 | Direct | |
Sierra Oncology, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 0 | Jul 1, 2022 | Direct | ||
TCR2 THERAPEUTICS INC. | Director | Stock Option (Right to Buy) | 0 | $0.74 | Jun 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
GRTS | Gritstone bio, Inc. | Jun 24, 2024 | 2 | $0 | 4 | Jun 26, 2024 | PRESIDENT AND CEO, Director |
GRTS | Gritstone bio, Inc. | May 15, 2024 | 3 | -$18.2K | 4 | May 17, 2024 | PRESIDENT AND CEO, Director |
GRTS | Gritstone bio, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 5, 2024 | PRESIDENT AND CEO, Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 5, 2023 | 6 | $0 | 4 | Jul 5, 2023 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 3, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jun 1, 2023 | 0 | $0 | 3 | Jun 1, 2023 | Director |
TCRR | TCR2 THERAPEUTICS INC. | Jun 1, 2023 | 6 | $0 | 4 | Jun 1, 2023 | Director |
GRTS | Gritstone bio, Inc. | Feb 2, 2023 | 1 | $0 | 4 | Feb 6, 2023 | President and CEO, Director |
TCRR | TCR2 THERAPEUTICS INC. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director |
SRRA | Sierra Oncology, Inc. | Jul 1, 2022 | 6 | -$90.8K | 4 | Jul 1, 2022 | Director, 10%+ Owner |
GRTS | Gritstone bio, Inc. | Jan 31, 2022 | 2 | $0 | 4 | Apr 20, 2022 | President and CEO, Director |
TCRR | TCR2 THERAPEUTICS INC. | Dec 9, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Director |
EPZM | Epizyme, Inc. | Jun 11, 2021 | 2 | $0 | 4 | Jun 15, 2021 | Director |
SRRA | Sierra Oncology, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |
GRTS | Gritstone bio, Inc. | Jan 7, 2021 | 1 | $0 | 4 | Nov 19, 2021 | President and CEO, Director |